Table 2 Baseline level and trend in monthly number of individuals per 100,000, MoH total expenditure^c, expenditure per treatment percapita^c, and out of pocket payment^c for diabetes and hypertension, and changes in level and trend by stage of the Farmácia Popular program, Brazil, 2006 to 2012

0.60

0.12

2.42

−1.74

(− 2.19 to − 1.29)

− 0.11

(− 0.14 to − 0.08)

−73.6

1.16

4.58

(4.09 to 5.08)

0.32

(0.28 to 0.36)

615.6

2.12

0.36

7.47

−4.42

(− 7.55 to − 1.29)

− 0.37

(− 0.58 to − 0.15)

−69.9

3.55

2.9

(− 0.35 to 6.16)

0.5

(0.3 to 0.8)

260.6

81.33

− 0.32

76.47

−13.93

(− 15.87 to − 11.99)

0.33

(0.2 to 0.46)

−14.3

61.98

42.87

(40.85 to 44.89)

0

(− 0.16 to 0.16)

69.0

33.07

−0.11

31.41

5.97

(−6.82 to 18.75)

−0.2

(−1.03 to 0.62)

12.4

30.88

−15.83

(− 28.67 to − 2.99)

0.49

(− 0.5 to 1.49)

−38.8

6.25

0.07

7.35

6.64

(4.0 to 9.27)

−0.21

(− 0.38 to − 0.03)

52.4

11.44

−12.27

(− 14.95 to − 9.59)

0.13

(− 0.08 to 0.34)

− 111.3

0.73

0.31

5.42

−4.88

(−6.63 to − 3.12)

−0.3

(− 0.42 to − 0.17)

− 86.0

1.46

15.5

(13.59 to 17.41)

0.85

(0.7 to 1.01)

1507.4

0.20

1.27

19.27

−19.4

(− 36.3 to − 2.4)

−1.3

(−2.4 to − 0.2)

− 93.3

2.38

34.6

(17.5 to 51.8)

0.74

(− 0.6 to 2.08)

1812.6

83.41

−0.05

82.65

−16.4

(− 18.8 to − 14)

0.3

(0.1 to 0.5)

−16.2

70.83

29.5

(26.9 to 32)

− 0.2

(− 0.4 to 0)

36.4

36.43

0.01

36.59

4.51

(−17.33 to 26.35)

−0.4

(− 1.81 to 1.01)

0.3

33.34

−14.6

(− 36.49 to 7.3)

0.44

(− 1.26 to 2.13)

−34.6

6.29

0.01

6.41

7.63

(4.04 to 11.21)

−0.21

(− 0.45 to 0.02)

80.8

9.94

−9.66

(−13.32 to − 5.99)

0.21

(− 0.08 to 0.49)

− 101.7